Incidence of interstitial pneumonitis among breast cancer patients: A 10-year Danish population-based cohort study

British Journal of Cancer

Volumn 98, Issue 11, 2008, Pages 1870-1875

  Christensen, S ^a   Pedersen, L ^a   Grijota, M ^a   Kornum, J B ^a   Beiderbeck, A ^b   Sorensen H T ^a,c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b GLAXOSMITHKLINE   (United Kingdom)

^c BOSTON UNIVERSITY   (United States)

Author keywords

Breast cancer; Epidemiology; Interstitial pneumonitis

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; DENMARK; HUMAN; HUMAN TISSUE; INFECTION RISK; INTERSTITIAL PNEUMONIA; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR;

AGED; BREAST NEOPLASMS; COHORT STUDIES; DENMARK; FEMALE; HUMANS; INCIDENCE; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED;

EID: 44349119710     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604393     Document Type: Article

References (22)

1. Andersen KW, Mouridsen HT (1988) Danish Breast Cancer Cooperative Group (DBCG). A description of the register of the nation-wide programme for primary breast cancer. Acta Oncol 27: 627-647
2. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH (1999) The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 46: 263-268
3. Bentzen SM, Skoczylas JZ, Overgaard M, Overgaard J (1996) Radiotherapy-related lung fibrosis enhanced by tamoxifen. J Natl Cancer Inst 88: 918-922
4. Burstein HJ, Bellon JR, Galper S, Lu HM, Kuter I, Taghian AG, Wong J, Gelman R, Bunnell CA, Parker LM, Garber JE, Winer EP, Harris JR, Powell SN (2006) Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer. Int J Radiat Oncol Biol Phys 64: 496-504
5. Camus P, Kudoh S, Ebina M (2004) Interstitial lung disease associated with drug therapy. Br J Cancer 91(Suppl 2): S18-S23
6. Cleverley JR, Screaton NJ, Hiorns MP, Flint JD, Muller NL (2002) Drug-induced lung disease: high-resolution CT and histological findings. Clin Radiol 57: 292-299
7. Coultas DB, Zumwalt RE, Black WC, Sobonya RE (1994) The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 150: 967-972
8. Cronin-Fenton DP, Norgaard M, Jacobsen J, Garne JP, Ewertz M, Lash TL, Sorensen HT (2007) Comorbidity and survival of Danish breast cancer patients from 1995 to 2005. Br J Cancer 96: 1462-1468
9. Dimopoulou I, Bamias A, Lyberopoulos P, Dimopoulos MA (2006) Pulmonary toxicity from novel antineoplastic agents. Ann Oncol 17: 372-379
10. Frank L (2000) Epidemiology. When an entire country is a cohort. Science 287: 2398-2399
11. Hunninghake GW, Zimmerman MB, Schwartz DA, King Jr TE, Lynch J, Hegele R, Waldron J, Colby T, Muller N, Lynch D, Galvin J, Gross B, Hogg J, Toews G, Helmers R, Cooper Jr JA, Baughman R, Strange C, Millard M (2001) Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 164: 193-196
12. Jensen AR, Overgaard J, Storm HH (2002) Validity of breast cancer in the Danish Cancer Registry. A study based on clinical records from one county in Denmark. Eur J Cancer Prev 11: 359-364
13. Lopez-Campos JL, Rodriguez-Becerra E (2004) Incidence of interstitial lung diseases in the south of Spain 1998-2000: the RENIA study. Eur J Epidemiol 19: 155-161
14. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, Kjaer M, Gadeberg CC, Mouridsen HT, Jensen MB, Zedeler K (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337: 949-955
15. Raghu G, Nyberg F, Morgan G (2004) The epidemiology of interstitial lung disease and its association with lung cancer. Br J Cancer 91(Suppl 2): S3-S10
16. Rothman KJ (2002) Epidemiology, an Introduction. Oxford University Press: New York
17. Sørensen HT (1997) Regional administrative health registers as a resource in clinical epidemiology. A study of options, strengths, limitations and data quality provided with examples of use. Int J Risk Safety Med 10: 1-22
18. Sorensen HT, Lash TL, Rothman KJ (2006) Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies. Hepatology 44: 1075-1082
19. Sorensen HT, Sabroe S, Olsen J (1996) A framework for evaluation of secondary data sources for epidemiological research. Int J Epidemiol 25: 435-442
20. Swigris JJ, Kuschner WG, Kelsey JL, Gould MK (2005) Idiopathic pulmonary fibrosis: challenges and opportunities for the clinician and investigator. Chest 127: 275-283
21. Taghian AG, Assaad SI, Niemierko A, Kuter I, Younger J, Schoenthaler R, Roche M, Powell SN (2001) Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. J Natl Cancer Inst 93: 1806-1811
22. Yu TK, Whitman GJ, Thames HD, Buzdar AU, Strom EA, Perkins GH, Schechter NR, McNeese MD, Kau SW, Thomas ES, Hortobagyi GN, Buchholz TA (2004) Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patients. J Natl Cancer Inst 96: 1676-1681